INSIDER · CIK 1676170
Coloma Jason V
Chief Executive Officer, Director at Maze Therapeutics, Inc. (MAZE)
↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$3.4MSold on the market
1Companies
Oct 2, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202616:12 | Oct 1, 2026 | MAZEMaze Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $27.02 | −34,501 | 191,447 | -15% | −$932K | ||
| Sep 4, 202616:24 | Sep 3, 2026from Sep 2, 2026 | MAZEMaze Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell | $26.24 | −22,638 | 27,362 | -45% | −$594K | ||
| Sep 3, 202616:27 | Sep 1, 2026 | MAZEMaze Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $26.29 | −34,501 | 223,355 | -13% | −$907K | ||
| Sep 3, 202616:27 | Sep 1, 2026 | MAZEMaze Therapeutics, Inc. | Chief Executive Officer, Director | M · Exercise10b5-1 | — | +50,000 | 50,000 | New | — | ||
| Aug 5, 202616:08 | Aug 3, 2026 | MAZEMaze Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $26.73 | −34,501 | 255,263 | -12% | −$922K |